Diary - News All news MaaT Pharma announces CE marking for its globally unique medical device

MaaT Pharma announces CE marking for its globally unique medical device

Lyon (France), June 15, 2017. A few days aftersigning a strategic partnership for the treatment of intestinal dysbiosis by FMT (Fecal Microbiota Transfer), MaaT Pharma pursues its industrialization process with the CE marking of the first ever stool collection and dilution device.

Quality, safety and reproducibility: more than a medical device, a technological breakthrough in the field of FMT

The necessary standardization of a booming activity requiring challenging safety rules ... The international protocols established by teams who practice FMT vary according to the indications treated and are intended to minimize the risk of transmission of pathogens.